Evidence map›Paper›PMID 33510207›Full record

ArticleScientific reports2021

Body surface area capping may not improve cytotoxic drugs tolerance.

Wafa Bouleftour, Agathe Viard, Benoite Mery, Robin Chaux, Nicolas Magne, Xavier Simoens, Romain Rivoirard, Fabien Forges

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wafa BouleftourMedical Oncology Department, Lucien Neuwirth Cancer Center, 42270, Saint Priest en Jarez, France. wafa.bouleftour@icloire.fr.
Agathe ViardPharmacy Department, Lucien Neuwirth Cancer Center, 42270, Saint-Priest en Jarez, France.
Benoite MeryMedical Oncology Department, Lucien Neuwirth Cancer Center, 42270, Saint Priest en Jarez, France.
Robin ChauxClinical Research, Innovation and Pharmacology Unit, University Hospital of Saint-Etienne, 42000, Saint Etienne, France.
Nicolas MagneRadiotherapy Department, Lucien Neuwirth Cancer Center, 42270, Saint Priest en Jarez, France.
Xavier SimoensPharmacy Department, Lucien Neuwirth Cancer Center, 42270, Saint-Priest en Jarez, France.
Romain RivoirardMedical Oncology Department, Lucien Neuwirth Cancer Center, 42270, Saint Priest en Jarez, France.
Fabien ForgesPharmacy Department, Lucien Neuwirth Cancer Center, 42270, Saint-Priest en Jarez, France.
Institute Cancer De La Loire Lucien Neuwirth · FRCentre Hospitalier Universitaire de Saint-Étienne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Capping body surface area (BSA) at 2 m

Indexed as

Body Surface AreaAgedAntineoplastic AgentsBody Mass IndexDose-Response Relationship, DrugDrug PrescriptionsDrug ToleranceFemaleHumansInjections, IntravenousLogistic ModelsMaleMiddle AgedAntineoplastic Agents

Identifiers

PMID33510207
PMCPMC7843991
OpenAlexW3123162599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.